Latest Funding News

Scorpion Minerals Limited has had its trading suspension lifted following an announcement about a potential joint venture and capital raising, signaling renewed market activity.

Ecofibre Limited has restructured its Australian loan facilities, extending repayment terms and adjusting interest rates to support a more sustainable financial footing.

Scorpion Minerals has expanded its footprint in the Murchison Gold Province through a strategic farm-in and joint venture agreement with E79 Gold Mines, aiming to earn a 70% stake in the Jungar Flats Gold Project. Supported by a $1.5 million placement, the company is poised to commence drilling on high-grade targets imminently.

Forbidden Foods Limited has raised $1 million to boost inventory for its Blue Dinosaur and Oat Milk Goodness brands, following a remarkable 104% jump in quarterly sales.

Asara Resources has raised $2.3 million through a placement led by Barbet L.L.C FZ to advance exploration at its Kada Gold Project in Guinea, coinciding with the appointment of Matthew Sharples as CEO.

WAM Capital has reported a robust 14.9% increase in its investment portfolio over six months, outperforming key ASX indices and maintaining its interim dividend at 7.75 cents per share.

Microequities Asset Management Group Limited has reported a robust 46.4% increase in profit after tax for the half-year ended December 2024, alongside a record $650 million in Funds Under Management and a raised interim dividend.

Westgold Resources reported a 72% jump in revenue to $624 million in H1 FY25, driven by increased gold production and higher prices, but posted a net loss after tax due to significant one-off acquisition expenses.

Pengana Capital Group reports a rise in Funds Under Management to $3.64 billion as of January 31, 2025, following significant distributions to investors. The firm’s half-year audited results are due next month, setting the stage for further insights.

Wellnex Life Limited has locked in A$9 million in conditional commitments to support its proposed dual listing on the London Stock Exchange’s AIM market, alongside launching a 1:1 entitlement offer for existing shareholders.

LGI Limited reports a solid H1 FY25 performance with modest revenue growth and increased EBITDA, driven by expanded biogas flows and carbon abatement activities. The company confirms a positive outlook with a 12-15% underlying EBITDA growth forecast for FY25.

Artrya Limited has launched a A$15 million capital raising to fund the development and commercial rollout of its Salix AI-powered coronary artery disease diagnostic platform, targeting the lucrative US healthcare market.